摘要
目的设计合成3,4-二氢喹啉-2(1H)-酮类化合物,考察其对D2、5-HT2A、5-HT1A受体的亲和力,并对代表化合物进行体内抗精神分裂活性测试。方法 7-羟基-3,4-二氢喹啉-2(1H)-酮与二卤代烷进行O-烷基化反应,再与相应的哌啶衍生物反应得到目标产物(Ⅰ1~Ⅰ11);对目标化合物进行了D2、5-HT2A、5-HT1A受体亲和力初步试验,并选择化合物Ⅰ7进行体内抗阿朴吗啡诱导的小鼠精神分裂模型实验。结果与结论共合成了11个新化合物,其结构经质谱及核磁共振氢谱确证。其中化合物Ⅰ7体内外活性良好,具有进一步研究的价值。
7-Aminoalkyloxy-3,4-dihydroquinolin-2(1H)-ones have D2 receptor affinity,and aromatic heterocyclic piperidines or piperazines have 5-HT2A and 5-HT1A affinity,These two fragments were introduced to one structure,with a public nitrogen atom.Eleven new 3,4-dihydroquinolin-2(1H)-one derivatives were designed and synthesized.This new serial compounds were prepared by the following method:7-hydroxyl-3,4-dihydroquinolin-2(1H)-one was reacted with dihalides as O-alkylation reaction to yield Ⅲ,and then the target compounds were prepared by Ⅲ and corresponding piperidine derivatives(Ⅰ1-Ⅰ11).The in vitro activities to D2,5-HT2A,5-HT1A receptors were tested for target compounds,their binding affinities to D2 and 5-HT1A are about 1-100 nmol · L-1,and to 5-HT2A are about 1-10 nmol · L-1.Their in vivo activity of apomorphine-induced stereotype in mice for representative compound Ⅰ7 were also tested,and it showed high inhibitory rate(70.23%) at 0.35 mg · kg-1(p.o.).Preliminary SAR indicates:The chain in the middle with three or four carbon atoms gives better activities to D2 and 5-HT2A,3-(piperazin-1-yl)benzo[d]isothiazole is more beneficial for 5-HT1A activity than 6-fluoro-3-(piperidin-4-yl)benzo[d]isoxazole.
出处
《中国药物化学杂志》
CAS
CSCD
2011年第2期81-87,共7页
Chinese Journal of Medicinal Chemistry
基金
国家十一五"重大新药创制"资助项目(2009ZX09103-048)